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 This paper attests that jatrorrhizine
has high binding afﬁnity with HSA.
 Jatrorrhizine effectively quenched the
ﬂuorescence of HSA molecules
through static mechanism.
 The energy transfer from HSA
molecules to jatrorrhizine occurs
with high probability.
 Experimental data show that
jatrorrhizine interacts with HSA
mainly via electrostatic force.
 Molecular calculation shows that p–p
staking and hydrogen bond also
stabilize the complex on site I.g r a p h i c a l a b s t r a c t
The binding behavior of jatrorrhizine with HSA was studied by UV–vis, ﬂuorescence and molecular mod-
eling examinations. Jatrorrhizine has high binding afﬁnity with HSA by effectively quenched the ﬂuores-
cence of HSA molecules via static mechanism. The binding sites, the type of interaction and the energy
transfer process were revealed. The thermodynamic parameters indicate that electrostatic force plays
an important role in the binding. The energy transfer from HSA molecules to jatrorrhizine occurs with
high probability.Furthermore, the molecular modeling was performed to explore the possible binding site
and assess the microenvironment around the bound jatrorrhizine.a r t i c l e i n f o
Article history:
Received 6 February 2013
Received in revised form 16 July 2013
Accepted 21 July 2013
Available online 27 July 2013
Keywords:
Jatrorrhizine
Human serum albumin
Fluorescence spectra
Interaction
Molecular modelinga b s t r a c t
In this work, the interaction of jatrorrhizine with human serum albumin (HSA) was studied by means of
UV–vis and ﬂuorescence spectra. The intrinsic ﬂuorescence of HSA was quenched by jatrorrhizine, which
was rationalized in terms of the static quenching mechanism. The results show that jatrorrhizine can
obviously bind to HSA molecules. According to ﬂuorescence quenching calculations, the bimolecular
quenching constant (kq), apparent quenching constant (KSV) at different temperatures were obtained.
The binding constants K are 4059 L mol1 and 1438 L mol1 at 299 K and 304 K respectively, and the num-
ber of binding sites n is almost 1. The thermodynamic parameters determined by the Van’t Hoff analysis of
the binding constants (DH 12.25 kJ mol1 and DS 28.17 J mol1 K1) clearly indicate that the electro-
static force plays a major role in the process. The efﬁciency of energy transfer and the distance between
the donor (HSA) and the acceptor (jatrorrhizine) were calculated as 22.2% and 3.19 nm according to
Föster’s non-radiative energy transfer theory. In addition, synchronous ﬂuorescence spectroscopy reveals
that jatrorrhizine can inﬂuence HSA’s microstructure. That is, jatrorrhizine is more vicinal to tryptophane
(Trp) residue than to tyrosine (Tyr) residue and the damage site is also mainly at Trp residue. Molecular
modeling result shows that jatrorrhizine–HSA complex formed not only on the basis of electrostatic forces,
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Scheme 1. The chemical structure of
J. Li et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 118 (2014) 48–54 49but also on the basis of p–p staking and hydrogen bond. The research results will offer a reference for the
studies on the biological effects and action mechanism of small molecule with protein.
 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license. Introduction
Studies on supramolecular interactions of drugs or organic dyes
with biological molecules have signiﬁcantly contributed to the
understanding of the structures and functions of bio-macromole-
cules and some biophysical processes [1]. By binding to HSA, most
drugs circulate in plasma and reach the target tissues and their
distribution is mainly controlled by HSA [2]. Therefore, drug bind-
ing to proteins has becomes an important determinant of pharma-
cokinetics, e.g. prolonging in vivo half-life, restricting the unbound
concentration and affecting distribution and elimination of the
drug [3]. Human serum albumin (HSA) is the most abundant
protein in human blood plasma and has high afﬁnity to many
endogenous and exogenous compounds, serving as a solubilizer
and transporter for drugs and other organic molecules to their
targets [4]. For these reasons, HSA is commonly used as a model
protein for biophysical and physicochemical studies [5]. The
globular protein consists of a single polypeptide chain of 585
amino acid residues and composed of three structurally similar
domains (I, II, and III). Many drugs could interact with protein by
multiple binding sites, thus the protein serve as an important
regulator of intercellular ﬂuxes.
Fluorometric method has been widely used because of its high
sensitivity, selectivity, convenience and providing more informa-
tion. The spectral change observed upon binding of a ﬂuorophore
to protein is a powerful tool for investigating the topology of bind-
ing site and the conformational changes and characterization of
bound substrate [6].
Jatrorrhizine (structure shown in Scheme 1) is one of the major
bioactive components isolated from tinospora cordifolia’s roots
[7,8]. The structure and medication of jatrorrhizine are same with
another alkaloid, berberine. Because of its excellent pharmacolog-
ical activity, antibacterial, antifungal and parasite ﬁghting abilities,
it is necessary to study the interaction between jatrorrhizine and
protein for understanding the mechanism of drug action at molec-
ular level. The understanding of the interaction of jatrorrhizine
with HSA is of utmost importance in formulating safe drugs and
effective dosages. Researches on some cationic alkaloids with pro-
tein have received rapidly rising interesting [9,10]. For example,
Zhang et al. [11] studied the interactions between three protoberb-
erine alkaloids and Bcl-2 by ﬂuorescence spectroscopy. They found
that three protoberberine alkaloids could quench the intrinsic ﬂuo-
rescence of Bcl-2 by static mechanism. Li et al. [12] studied the
interaction between jatrorrhizine and human gamma globulin
(HGG) in AOT/isooctane/water microemulsions by using ﬂuores-O
O
CH3
CH3
1
jatrorrhizine.cence quenching, UV absorption spectroscopy, circular dischroism
(CD) spectroscopy and dynamic light scattering. Chen et al. [13]
studied the interaction of jatrorrhizine with HSA using ﬂuores-
cence, but the results are limited to binding constants. The detailed
and systematic investigations on the interaction of jatrorrhizine
with HAS is still rarely been reported and are very limited.
We have previously reported the spectrocopic studies to char-
acter the interaction of some alkaloids with ctDNA [14,15]. In this
paper, the complexation behavior of jatrorrhizine with HSA was
studied by UV–vis, ﬂuorescence and molecular modeling examina-
tions. The ﬂuorescence quenching mechanism of HSA by jatrorrhi-
zine, the binding sites, the type of interaction and the energy
transfer process were revealed. Attempts were also made to inves-
tigate the thermodynamic parameters for the reaction and the
effect of jatrorrhizine on the protein secondary structure. The re-
sults indicate that electrostatic force played an important role in
the binding due to the opposite charge on the jatrorrhizine and
the protein. Furthermore, the molecular modeling was performed
to explore the possible binding site and assess the microenviron-
ment around the bound jatrorrhizine. The binding properties of jat-
rorrhizine to HSA elucidated in this study may provide some useful
clues for future application of this kind of drugs as a photosensi-
tizer for anticancer treatment.
Materials and methods
Materials
HSA was purchased from Sigma Chemical Corporation. A
1  104 mol L1 stock solution was prepared by dissolving the
solid HSA in 0.5% NaCl solution and stored at 0–4 C. Jatrorrhizine
(AR grade) was obtained from the national institute for the control
of pharmaceutical and biological products (Beijing, China), and a
stock solution (1  103 mol L1) was prepared by dissolving an
appropriate amount of jatrorrhizine into doubly distilled water.
Tris–HCl (pH = 7.40) buffer solution was used to control the solu-
tion pH.
Apparatus and methods
The absorption spectra were obtained on a UV-2450 dual-beam
UV–vis spectrophotometer (Shimadzu, Japan). A F-4500 spectroﬂu-
orometer (Hitachi, Japan) equipped with a 150W xenon lamp and
a thermostatic bath was used for the measurement of ﬂuorescence
spectra. Instrument settings, i.e. the slit widths (excitation at
5.0 nm; emission at 5.0 nm). Fluorescence spectra of HSA were
obtained with excitation at 296 nm. One centimeter quartz cells
were used through out the experiments. Solution pH values were
measured with a pHS-3C pH meter (Shanghai REX Instrument
Factory, China) with a combined glass electrode.
Procedures of ﬂuorescence measurement
HSA stock solution was transferred to a 10 mL volumetric ﬂask,
diluted to the ﬁnal volume with a pH 7.40 Tris–HCl buffer solution.
The interaction between jatrorrhizine and HSA was investigated by
ﬂuorometric titration. An exact 2.5 mL portion of 1  105 mol L1
HSA solution was added to a 1.0 cm quartz cell, and then titrated
by successive additions of 1.0  102 mol L1 jatrorrhizine with a
5 mL microsyringe to attain a series of ﬁnal concentrations. The
50 J. Li et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 118 (2014) 48–54titrations were operated manually with gentle stirring. All mea-
surements of absorption and ﬂuorescence were made against a
blank solution. When experiments were carried out at different
temperatures (290 and 310 K), the solution was equilibrated in a
thermostatic bath. All test solutions were incubated for 10 min be-
fore measurement.
The determination of synchronous ﬂuorescence spectra
In order to conﬁrm the binding sites of jatrorrhizine to HSA
molecules, the synchronous ﬂuorescence spectra of HSA solutions
along with the increase of jatrorrhizine concentrations were re-
searched in wavelength ranges from 250 nm to 350 nm for
Dk = 15 nm and from 225 nm to 325 nm for Dk = 60 nm.
Molecular modeling examinations
The potential of the 3D structure (entry codes 1E78) of HSA was
assigned according to the CFF91 force ﬁeld. The initial structure of
jatrorrhizine was generated by molecular modeling platform
Insight II 2000 (Accelrys), and the geometries of the jatrorrhizine
were subsequently optimized by using the CFF91 force ﬁeld. The
docking method was used to calculate the binding modes of jatror-
rhizine with HSA. All calculations were performed on an SGI
workstation.400 450 500 550 600
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Fig. 2. Emission spectra of jatrorrhizine (2  105 mol L1) with the increase
concentrations of HSA concentrations for HSA are (106 mol L1): 0, 0.62, 3.13,
4.38, 7.50, 8.74, 14.38, 16.25, 20.00, 21.88, 23.75, 31.25, 34.38, 37.5, 40.63, 46.88,
50.0, 56.25, 62.50.Results and discussion
Absorption spectral behavior of jatrorrhizine with HSA
The absorption spectra of jatrorrhizine in the presence of HSA at
different concentrations are shown in Fig. 1. As shown in Fig. 1,
HSA showed one absorption band at about 280 nm. Upon increas-
ing the concentration of jatrorrhizine, the absorbance at 280 nm
was gradually increased with a slight blue shift to 275 nm, and a
new peak appeared and increased at longer wavelength between
300 and 400 nm. This indicates that there is a strong interaction
of jatrorrhizine and HSA, complexation may formed.
Fluorescence spectra of HSA solutions with jatrorrhizine
The ﬂuorescence spectral changes of jatrorrhizine upon addi-
tion of HSA are shown in Fig. 2. The ﬂuorescence maximum slightly
shifts to shorter wavelengths with signiﬁcant intensity enhance-250 300 350
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Fig. 1. Absorption spectra of jatrorrhizine with HSA/concentration of HSA:
5  106 mol L1; concentrations of jatrorrhizine (curves 1–13,106 mol L1): 0,
0.8, 1.6, 5.6, 7.2, 8.8, 10.4, 16, 28, 32, 40, 56, 64.ment. These spectral changes indicate the formation of jatrorrhi-
zine–HSA complex.
In addition, the ﬂuorescence spectra of HSA in the presence of
jatrorrhizine at different concentrations are shown in Fig. 3. It is
well known that most of protein molecules naturally ﬂuoresce
around 350 nm (under 290 nm wavelength excitation), which
mainly attributes to their ﬂuorescent Trp residues [16]. In Fig. 3,
the ﬂuorescence intensity of HSA was decreased gradually and
the ﬂuorescence maxima showed red shift from 359 nm to
371 nm by increasing the jatrorrhizine concentration. Apparently,
this quenching is owing to the interaction of jatrorrhizine with
HSA molecules. Thus the microenvironment of ﬂuorescence chro-
mophore and conformation of HSA was changed.Interaction mode
Usually, the ﬂuorescence quenching of protein by small mole-
cules can be static and/or dynamicin nature. These two quenching
mechanisms are distinguishable by examining the temperature
dependence behavior of quenching rate constant, as static quench-
ing is discouraged at higher temperatures but dynamic quenching
is accelerated [17]. The ﬂuorescence quenching behavior of protein
and the Stern–Volmer analysis of the relative ﬂuorescence inten-300 350 400 450 500
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Fig. 3. Emission spectra of HSA (5  106 mol L1) containing jatrorrhizine (106 -
mol L1) of 0, 0.8, 1.6, 2.4, 3.2, 4.0, 5.6, 7.2, 8.8, 10.4, 12, 14.4, 16.8, 21.6, 24, 28, 32,
36, 40. [Tris–HCl] = [NaCl] = 50 mmol/L, pH = 7.40.
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temperatures were employed to elucidate the quenching mecha-
nism and rates.
As a hypothetical dynamic quenching process, the quenching
rate constants were determined by using the Stern–Volmer equa-
tion [17]:
F0=F ¼ 1þ kqs0½Q  ¼ 1þ KSV ½Q  ð1Þ
where F and F0 are the ﬂuorescence intensity in the presence and
absence of jatrorrhizine, respectively, kq the quenching rate con-
stant, KSV the Stern–Volmer constant, s0 the ﬂuorescence lifetime
of HSA in the absence of jatrorrhizine and [Q] is the concentration
of jatrorrhizine.
KSV ¼ kqs0 ð2Þ
Fig. 4 displays the Stern–Volmer plots of HSA solutions in the
presence of jatrorrhizine with various concentrations. As can be
seen from Fig. 6, the Stern–Volmer plots are linear and the slope
decreases with increasing temperature, which indicates that the
quenching process is static. In general, the ﬂuorescence lifetime
s0 of HSA was reported approximately as 108 s [18] and the KSV
value was obtained from the slope of the Stern–Volmer plot
(Fig. 6). By using Eq. (2), the quenching constants kq at different
temperatures were determined as shown in Table 1. The obtained
kq values are in the range of 1012 L mol1 s1, which far exceed the
diffusion controlled rate constant in aqueous solution, i.e.
2.0  1010 L mol1 s1 [19], conﬁrming that quenching does not in-
volve the dynamic diffusion process but occurs statically in the
complex. It can be found that both plots exhibit a comparatively
good linear relationship. It indicates that the dominating quench-
ing mechanism is not dynamic but static.Binding constant and the binding sites
The binding constant and binding site number n can be ob-
tained from the site binding model which assumes the existence0 5 10 15 20 25
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Fig. 4. Stern–Volmer curves for the binding of jatrorrhizine with HSA at different
temperatures. Excitation wavelength is 290 nm.
Table 1
Dynamic quenching rate constants and correlation coefﬁcient at different
temperatures.
T (K) KSV (L mol1) Kq (L mol1 s1) R
299 2.89  104 2.89  1012 0.9962
304 2.79  104 2.79  1012 0.9974of n independent binding sites for a quencher (Q) in a biomolecule
molecule and is expressed in Eq. (3):
log
F0  F
F
¼ log K þ n log½Q  ð3Þ
where F0 and F are the ﬂuorescence intensities in the absence and
presence of jatrorrhizine, Ka the binding constant of jatrorrhizine
with HSA, and n is the number of binding sites. Thus, the experi-
mental values of log[(F0  F)/F] were plotted as a function of log[Q]
to give a good straight line at each temperature, as shown in Fig. 5.
The relevant data derived from these experiments are shown in Ta-
ble 2. The Ka values are 4059 L mol1 and 1438 L mol1 at 299 K and
304 K respectively, indicating moderately strong binding between
the HSA molecules and jatrorrhizine. The binding site numbers n
are about 1 indicating that there has only one site for the binding
of jatrorrhizine to HSA molecule.
The forces contributing to the complexation of jatrorrhizine with HSA
The forces enabling the binding of a drug with a biomolecule are
composed of various weak non-covalent interactions including the
hydrophobic, electrostatic, vander Waals and hydrogen-bonding
interactions. To obtain further insights into the weak interactions
associated with the complexation of jatrorrhizine with HSA, we
endeavored to determine the thermodynamic parameters by using
the Van’t Hoff equation. If the enthalpy change (DH) does not sig-
niﬁcantly vary over the temperature range studied, then the ther-
modynamic parameters can be determined by using the Van’t Hoff
equation [20]:
ln K ¼ DH=RT þ DS=R ð4Þ
where Ka is the binding constant at each temperature T (absolute
temperature) and R is the gas constant. Ploting lnK versus 1/T, the
Van’t Hoff plots gave relatively good straight lines and the DH
and DS values calculated from the slope and intercept of the plot
are shown in Table 3. The free energy change (DG) was calculated
by Eq. (5) at each temperature:
DG ¼ RT ln K ¼ DH  TDS ð5Þ-6.2 -6.0 -5.8 -5.6 -5.4 -5.2 -5.0 -4.8 -4.6
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Fig. 5. Lineweaver–Burk plot of HSA solution with jatrorrhizine concentrations.
Table 2
Binding constants and binding sites of jatrorrhizine with HSA at different
temperatures.
T (K) K (L mol1) n R
299 4059 0.8007 0.9950
304 1438 0.7172 0.9990
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of the thermodynamic parameters to characterize the major inter-
action working in a variety of host guest systems. In the present
case, the enthalpic change < 0 and the entropic change > 0, indicat-
ing that the host guest system is driven by the electrostatic inter-
actions. Jatrorrhizine carries a positive charge in aqueous solution,
thus the binding of jatrorrhizine to HSA might involve electrostatic
interactions. The negative signs for DG indicate the spontaneity of
the binding of three jatrorrhizine to HSA molecules under standard
conditions.300 350 400 450 500
0.00
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F
Fig. 6. The overlap of the absorption spectrum of jatrorrhizine and ﬂuorescence
spectrum of HSA. The ratio for jatrorrhizine and HSA is 1:1.
20
40
60
80
F
lu
o
re
s
c
e
n
c
e
in
te
n
s
it
y
1
7Energy transfer between jatrorrhizine and HSA
The ﬂuorescence quenching of HSA and the ﬂuorescence
enhancement of jatrorrhizine upon complexation of jatrorrhizine
with HSA indicate that the energy transfer between jatrorrhizine
and HSA takes place. The transfer efﬁciency can be used for quan-
titatively estimating the distance between the relevant protein res-
idue (donor) and the bound dye (acceptor). The energy transfer
efﬁciency between jatrorrhizine and HSA was studied according
to the Förster’s energy transfer theory [22]. The Förster theory
shows that energy transfer is affected not only by the distance be-
tween the acceptor and the donor, but also by the critical distance
of energy transfer (R0), which can be calculated by using the fol-
lowing equation:
E ¼ 1 F
F0
¼ R
6
0
R60 þ r6
ð6Þ
where E is the energy transfer efﬁciency, F and F0 the ﬂuorescence
intensities of biomolecule in the presence and absence of quencher,
r the donor–acceptor distance and R0 is the critical distance where
the transfer efﬁciency is 50%:
R60 ¼ 8:8 1025K2N4/DJ ð7Þ
where K2 is the space factor of orientation, N the refractive index of
the medium, F the ﬂuorescence quantum yield of donor, and J is the
effect of the spectral overlap between the emission spectrum of the
donor and the absorption spectrum of the acceptor, which could be
calculated as:
J ¼
P
FðkÞðkÞk4Dk
P
FðkÞDk ð8Þ
where F(k) is the corrected ﬂuorescence intensity of the donor in the
wavelength range of k to (k + Dk) and e(k) the molar extinction coef-
ﬁcient of the acceptor in the wavelength range of k to (k + Dk).
Fig. 6 shows the overlap of the UV–vis absorption spectrum of
jatrorrhizine with the ﬂuorescence emission spectrum of HSA. In
the present case, K2 = 2/3, N = 1.336 and u = 0.188 for HSA [23].
Eqs. (6)–(8) gave the following values: J = 1.71  1014 cm3
L mol1, R0 = 2.59 nm, E = 0.22 and r = 3.19 nm. Since the average
distance r < 7 nm [24] and 0.5R0 < r < 1.5R0 [25], the energy trans-
fer from HSA to jatrorrhizine occurred with high probability. The
average distance is shorter than 7 nm upon interaction of jatrorrhi-
zine with HSA, which is well within the conditions required for
applying the Förster’s non-radiative energy transfer theory, again
supporting the static quenching interaction between jatrorrhizine
and HSA.Table 3
Thermodynamic parameters of jatrorrhizine with HSA.
T (K) DH (kJ mol1) DS (J mol1 K1) DG (kJ mol1)
299 12.25 28.17 20.68
304 20.81Synchronous ﬂuorescence spectra of HSA solutions
The ﬂuorescence of protein comes from Trp and Tyr residues.
The ﬂuorescence of Trp and Tyr residues are highly sensitive to
the polarity of its environment. Thus, the emission shifts of these
residues could be employed to examine the conformational
changes of protein. Synchronous ﬂuorescence spectra can provide
much valuable information about the microenvironment around
ﬂuorogens in biomolecules [26]. In general, for protein molecules,
when the Dk = 15 nm is ﬁxed, the spectrum characteristic of Tyr
residues will be observed, while when the Dk = 60 nm is done,
the spectrum characteristic of Trp residues will be observed
[27,28]. In this work, the synchronous ﬂuorescence spectroscopy
was used to get the information about the binding sites of jatror-
rhizine to HSA molecules. It can be seen from Figs. 7a and 7b, the
ﬂuorescence intensities for HSA are quenched with increasing con-
centration of jatrorrhizine. When Dk = 60 nm, the ﬂuorescence
quenching intensity extent is signiﬁcantly bigger than that of
Dk = 15 nm. The emission wavelength red shift for Dk = 60 nm
while wavelength number for Dk = 15 nm does not changed. This
reveals that hydrophobic and hydrophilic of the microenvironment
of Tyr residues has no obvious change. Red shift means the
decrease of hydrophobic and increase of hydrophilic of the
microenvironment of Trp residues. The wave become wide, indi-
cating the stretch of HSA molecule after binding. It reveals that jat-
rorrhizine binds to HSA molecules with more accessibility to Trp260 280 300 320 340
0
Wavelength/nm
Fig. 7a. Fluorescence spectra of jatrorrhizine with HSA Dk ¼ 15 nm, concentration
for HSA: 5  106 mol L1, concentrations for jatrorrhizine (106 mol L1) 1–7:
0,4, 8, 12, 16, 20, 24.
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Fig. 7b. Fluorescence spectra of jatrorrhizine with HSA Dk ¼ 60 nm, concentration
for HSA: 5  106 mol L1, concentrations for jatrorrhizine (106 mol L1) 1–7: 0,
4, 8, 12, 16, 20, 24.
J. Li et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 118 (2014) 48–54 53residues than Tyr residues. This binding mode affects the microen-
vironment of Trp residues.
The molecular modeling of jatrorrhizine binding to HSA
To clearly describe the interaction between jatrorrhizine and
HSA, the molecular modeling studies were carried out. The aim
of molecular modeling study is to promote the visual understand-
ing of the binding site on atomic level. HSA is a globular protein
consisting of a single peptide chain of 585 amino acids. It is com-
posed of three homologous domains, I, II and III, which have similar
three-dimensional structures [29]. Each domain can be divided
into two subdomains A and B, which have six (A) and four (B)
a-helices. The principal binding regions on HSA are located in sub-
domains IIA (drug binding site1) and IIIA (drug binding site 2) [30].
The inside wall of the pocket of subdomain IIA, which corresponds
to the so-called site 1, is formed by hydrophobic side chains, where
as the entrance of the pocket is surrounded by positively charged
residues such as RG218 and LYS195 [31]. The crystal structure of
the HSA complex of halothane, one of the most widely used general
anesthetics, was taken from the Brookhaven protein Data Bank
(entry codes 1E78) [32]. All calculations were performed with mol-
ecules modeling platform Insight II2000 (Accelrys). Discover 3.0
program was applied to calculate the possible conformation of
the ligands that bind to the protein. All binding parameters of
the system were calculated on SGI workstations. The best energy
ranked result of the binding mode of with HSA is shown in Fig. 8.
The optimal binding model is that jatrorrhizine is situated with-
in subdomain IIA in Sudlow’s site I of HSA. Although ring 3 of jat-Fig. 8. The best binding mode between jatrorrhizine and HSA. The important
neighboring residues of HSA are represented using lines and the ligand structure is
represented using a ‘‘ball and stick’’ format.rorrhizine molecule is slightly not coplanar with 1-ring and 2-ring,
the practically planar structure of jatrorrhizine is propitious to its
binding to HSA molecules. The key residues interacting with jatror-
rhizine are shown in Fig. 8. It can be seen from the ﬁgure that elec-
trostatic interaction between the positive charged N atom of
jatrorrhizine and carboxyl of ASP-451 nearing Trp-214 residue is
the main interaction, which is in agreement with the result of
the ﬂuorescence study. It is reasonable that electrostatic force
drives jatrorrhizine molecule to a close proximity to Trp-214
residue, so the ﬂuorescence quenching is caused by energy transfer
from Trp-214 to jatrorrhizine when jatrorrhizine molecule moves
into subdomain IIA. In addition, p–p staking of 1-ring of jatrorrhi-
zine and Trp-214 of HSA, hydrogen bond between hydroxy of
4-ring of jatrorrhizine and carboxyl of Glu-450 of HSA also play
important roles in stabilizing the jatrorrhizine and HSA complex.Conclusions
The interactions of jatrorrhizine with HSA molecules in aqueous
solution were investigated by ﬂuorescence spectroscopy. The
experimental results show that jatrorrhizine binds to HSA mole-
cules and efﬁciently quench its intrinsic ﬂuorescence by static
mechanism. Moderately strong binding exist between the HSA
molecules and jatrorrhizine. In addition, the synchronous ﬂuores-
cence spectroscopy shows that jatrorrhizine is more accessibility
to the Trp residues of HSA molecules than Tyr residues. Molecular
modeling result shows that jatrorrhizine–HSA complex formed not
only on the basis of electrostatic forces, but also on the basis of p–p
staking and hydrogen bond.
Acknowledgments
The authors greatly acknowledge the National Natural Science
Foundation of China (Nos. 21175086, 21105060, and 20971081),
Shanxi Province Natural Science Foundation (No. 2010011013-1)
for ﬁnancial support.
References
[1] I.T. Prud’homme, O. Zoueva, J.M. Weber, Clin. Diagn. Virol. 8 (1997) 41.
[2] N. Shahabadi, M. Maghsudi, J. Mol. Struct. 929 (2009) 193.
[3] T. Peters, All About Albumin, Academic Press, San Diego, CA, 1996.
[4] W.H. Ang, E. Daldini, L. Juillerat-Jeanneret, P.J. Dyson, Inorg. Chem. 46 (2007)
9048.
[5] W.Y. Choi, S.J. Kim, N.J. Lee, M. Kwon, I.S. Yang, M.J. Kim, S.G. Cheong, D. Kwon,
J.Y. Lee, H.B. Oh, C. Kang, Antivir. Res. 84 (2009) 199.
[6] N. Seedher, S. Bhatia, Pharmacol. Res. 54 (2006) 77.
[7] N. Yang, Y. Song, H. Sampson, X. Li, J. Allergy Clin. Immun. 127 (2011) 240.
[8] Y.C. Deng, M. Zhang, H.Y. Luo, Ind. Crops Prod. 37 (2012) 298.
[9] C.C. Zhao, W.F. Zheng, M.Q. Li, J. Anal. Sci. 20 (2004) 275.
[10] H. Hulvová, P. Galuszka, J. Frébortová, I. Frébort, Biotechnol. Adv. 31 (2013) 79.
[11] Y.X. Zhang, X.F. Zhang, Y.L. Tang, J.F. Xiang, M.Y. Tian, Acta Chim. Sinica 69
(2011) 247.
[12] Y. Li, C. Wang, G.H. Lu, J. Mol. Struct. 980 (2010) 108.
[13] A.G. Chen, D.Z. Su, J.C. Gao, J. Shanxi Med. Univ. 30 (1999) 91.
[14] J.F. Li, B.H. Li, Y.B. Wu, S.M. Shuang, C. Dong, M.M.F. Choi, Spectrochim. Acta A
95 (2012) 80.
[15] J.F. Li, W.T. Shi, X.Y. Han, C. Dong, M.M.F. Choi, Chem. Res. Chin. Univ. 28 (2012)
614.
[16] A. Sulkowska, J. Mol. Struct. 614 (2002) 227.
[17] J.R. Lakowicz, Principles of Fluorescence Spectroscopy, second ed., Plenum
Press, New York, 1999. pp. 237.
[18] A.M. Bordbar, A.K. Safaei, E. Ghasemi, J. Mol. Struct. 705 (2004) 41.
[19] P.B. Kandagal, J. Seetharamappa, S.M.T. Shaikh, D.H. Manjunatha, J. Photochem.
Photobiol. A 185 (2007) 239.
[20] N. Juziro, M. Noriko, Chem. Pharm. Bull. 33 (1985) 2522.
[21] P.D. Ross, S. Subramanian, Biochemistry 20 (1981) 3096.
[22] T. Förster, in: O. Sinanoglu (Ed.), Modern Quantum Chemistry, vol. 3, Academic
Press, New York, 1996.
[23] L. Cyril, J.K. Earl, W.M. Sperry, Biochemists’ Handbook, E. & F.N. Spon, London,
1961. p.84.
[24] B. Valeur, J.C. Brochon, New Trends in Fluorescence Spectroscopy, sixth ed.,
Springer Press, Berlin, 1999. p. 25.
54 J. Li et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 118 (2014) 48–54[25] B. Valeur, Molecular Fluorescence: Principles and Applications, Wiley Press,
New York, 2001. p. 250.
[26] S. Rubio, A. Gomez-Hens, M. Valcarcel, Talanta 33 (1986) 633.
[27] F.L. Cui, J.L. Wang, Y.R. Cui, J.P. Li, Anal. Chim. Acta 571 (2006) 175.
[28] M. Dockal, D.C. Carter, F. Ruker, J. Biol. Chem. 275 (2000) 3042.[29] G. Sudlow, D.J. Birkett, D.N. Wade, Mol. Pharmacol. 12 (1976) 1052.
[30] Y.V. Ilˇichev, J.L. Perry, J.D. Simon, J. Phys. Chem. B 106 (2002) 452.
[31] I. Sjoholm, B. Ekman, A. Kober, I. Ljungstedt-Pahlman, B. Seiving, T. Sjodin, Mol.
Pharmacol. 16 (1979) 767.
[32] A.A. Bhattacharys, S. Curry, N.P. Franks, J. Biol. Chem. 275 (2000) 38731.
